ID   MDHM_HUMAN              Reviewed;         338 AA.
AC   P40926; A8K414; B2RE78; B4DE44; E9PDB2; O43682;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 3.
DT   10-MAY-2017, entry version 180.
DE   RecName: Full=Malate dehydrogenase, mitochondrial;
DE            EC=1.1.1.37 {ECO:0000269|PubMed:27989324};
DE   Flags: Precursor;
GN   Name=MDH2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT VAL-9.
RA   Hu G.;
RT   "Human homolog of mouse and pig MDH mRNA.";
RL   Submitted (FEB-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Kidney, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT VAL-9.
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-165; LYS-185; LYS-301;
RP   LYS-314; LYS-329 AND LYS-335, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [9]
RP   ACETYLATION AT LYS-185; LYS-301; LYS-307 AND LYS-314, ENZYME
RP   REGULATION, IDENTIFICATION BY MASS SPECTROMETRY, AND MUTAGENESIS OF
RP   LYS-185; LYS-301; LYS-307 AND LYS-314.
RX   PubMed=20167786; DOI=10.1126/science.1179689;
RA   Zhao S., Xu W., Jiang W., Yu W., Lin Y., Zhang T., Yao J., Zhou L.,
RA   Zeng Y., Li H., Li Y., Shi J., An W., Hancock S.M., He F., Qin L.,
RA   Chin J., Yang P., Chen X., Lei Q., Xiong Y., Guan K.L.;
RT   "Regulation of cellular metabolism by protein lysine acetylation.";
RL   Science 327:1000-1004(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   MALONYLATION AT LYS-307.
RX   PubMed=21908771; DOI=10.1074/mcp.M111.012658;
RA   Peng C., Lu Z., Xie Z., Cheng Z., Chen Y., Tan M., Luo H., Zhang Y.,
RA   He W., Yang K., Zwaans B.M., Tishkoff D., Ho L., Lombard D., He T.C.,
RA   Dai J., Verdin E., Ye Y., Zhao Y.;
RT   "The first identification of lysine malonylation substrates and its
RT   regulatory enzyme.";
RL   Mol. Cell. Proteomics 10:M111.012658.01-M111.012658.12(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-246 AND SER-326, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [15]
RP   INVOLVEMENT IN EIEE51, VARIANTS EIEE51 ARG-37; LEU-133 AND LEU-207,
RP   CHARACTERIZATION OF VARIANTS EIEE51 LEU-133 AND LEU-207, AND CATALYTIC
RP   ACTIVITY.
RX   PubMed=27989324; DOI=10.1016/j.ajhg.2016.11.014;
RA   Ait-El-Mkadem S., Dayem-Quere M., Gusic M., Chaussenot A.,
RA   Bannwarth S., Francois B., Genin E.C., Fragaki K., Volker-Touw C.L.,
RA   Vasnier C., Serre V., van Gassen K.L., Lespinasse F., Richter S.,
RA   Eisenhofer G., Rouzier C., Mochel F., De Saint-Martin A.,
RA   Abi Warde M.T., de Sain-van der Velde M.G., Jans J.J., Amiel J.,
RA   Avsec Z., Mertes C., Haack T.B., Strom T., Meitinger T., Bonnen P.E.,
RA   Taylor R.W., Gagneur J., van Hasselt P.M., Roetig A., Delahodde A.,
RA   Prokisch H., Fuchs S.A., Paquis-Flucklinger V.;
RT   "Mutations in MDH2, encoding a Krebs cycle enzyme, cause early-onset
RT   severe encephalopathy.";
RL   Am. J. Hum. Genet. 100:151-159(2017).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 20-338 IN COMPLEX WITH NAD
RP   AND SUBSTRATE, AND SUBUNIT.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human malate dehydrogenase type 2.";
RL   Submitted (MAR-2006) to the PDB data bank.
CC   -!- CATALYTIC ACTIVITY: (S)-malate + NAD(+) = oxaloacetate + NADH.
CC       {ECO:0000269|PubMed:27989324}.
CC   -!- ENZYME REGULATION: Enzyme activity is enhanced by acetylation.
CC       {ECO:0000269|PubMed:20167786}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|Ref.16}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix
CC       {ECO:0000250|UniProtKB:P04636}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P40926-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P40926-2; Sequence=VSP_055312;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: Acetylation is enhanced by up to 67% after treatment either
CC       with trichostin A (TSA) or with nicotinamide (NAM) with the
CC       appearance of tri- and tetraacetylations. Glucose also increases
CC       acetylation by about 60%. {ECO:0000269|PubMed:20167786}.
CC   -!- DISEASE: Epileptic encephalopathy, early infantile, 51 (EIEE51)
CC       [MIM:617339]: A form of epileptic encephalopathy, a heterogeneous
CC       group of severe childhood onset epilepsies characterized by
CC       refractory seizures, neurodevelopmental impairment, and poor
CC       prognosis. Development is normal prior to seizure onset, after
CC       which cognitive and motor delays become apparent. EIEE51 is an
CC       autosomal recessive form characterized by onset of intractable
CC       seizures and hypotonia in the first days or weeks of life, and
CC       severely delayed psychomotor development.
CC       {ECO:0000269|PubMed:27989324}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the LDH/MDH superfamily. MDH type 1 family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Malate dehydrogenase entry;
CC       URL="https://en.wikipedia.org/wiki/Malate_dehydrogenase";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF047470; AAC03787.1; -; mRNA.
DR   EMBL; AK290779; BAF83468.1; -; mRNA.
DR   EMBL; AK293460; BAG56955.1; -; mRNA.
DR   EMBL; AK316587; BAG38175.1; -; mRNA.
DR   EMBL; AC005077; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC006330; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471220; EAW71796.1; -; Genomic_DNA.
DR   EMBL; BC001917; AAH01917.1; -; mRNA.
DR   CCDS; CCDS5581.1; -. [P40926-1]
DR   CCDS; CCDS64691.1; -. [P40926-2]
DR   RefSeq; NP_001269332.1; NM_001282403.1. [P40926-2]
DR   RefSeq; NP_001269333.1; NM_001282404.1.
DR   RefSeq; NP_005909.2; NM_005918.3. [P40926-1]
DR   UniGene; Hs.520967; -.
DR   PDB; 2DFD; X-ray; 1.90 A; A/B/C/D=20-338.
DR   PDB; 4WLE; X-ray; 1.90 A; A/B/C/D=20-338.
DR   PDB; 4WLF; X-ray; 2.20 A; A/B/C/D=20-338.
DR   PDB; 4WLN; X-ray; 2.28 A; A/B/C/D=20-338.
DR   PDB; 4WLO; X-ray; 2.50 A; A/B/C/D=20-338.
DR   PDB; 4WLU; X-ray; 2.14 A; A/B/C/D=20-338.
DR   PDB; 4WLV; X-ray; 2.40 A; A/B/C/D=20-338.
DR   PDBsum; 2DFD; -.
DR   PDBsum; 4WLE; -.
DR   PDBsum; 4WLF; -.
DR   PDBsum; 4WLN; -.
DR   PDBsum; 4WLO; -.
DR   PDBsum; 4WLU; -.
DR   PDBsum; 4WLV; -.
DR   ProteinModelPortal; P40926; -.
DR   SMR; P40926; -.
DR   BioGrid; 110356; 51.
DR   IntAct; P40926; 13.
DR   MINT; MINT-1408946; -.
DR   STRING; 9606.ENSP00000327070; -.
DR   BindingDB; P40926; -.
DR   ChEMBL; CHEMBL5917; -.
DR   DrugBank; DB04272; Citric Acid.
DR   DrugBank; DB00157; NADH.
DR   iPTMnet; P40926; -.
DR   PhosphoSitePlus; P40926; -.
DR   SwissPalm; P40926; -.
DR   BioMuta; MDH2; -.
DR   DMDM; 215274114; -.
DR   DOSAC-COBS-2DPAGE; P40926; -.
DR   REPRODUCTION-2DPAGE; IPI00291006; -.
DR   REPRODUCTION-2DPAGE; P40926; -.
DR   UCD-2DPAGE; P40926; -.
DR   EPD; P40926; -.
DR   MaxQB; P40926; -.
DR   PaxDb; P40926; -.
DR   PeptideAtlas; P40926; -.
DR   PRIDE; P40926; -.
DR   TopDownProteomics; P40926-1; -. [P40926-1]
DR   DNASU; 4191; -.
DR   Ensembl; ENST00000315758; ENSP00000327070; ENSG00000146701. [P40926-1]
DR   Ensembl; ENST00000432020; ENSP00000408649; ENSG00000146701. [P40926-2]
DR   GeneID; 4191; -.
DR   KEGG; hsa:4191; -.
DR   UCSC; uc003ueo.5; human. [P40926-1]
DR   CTD; 4191; -.
DR   DisGeNET; 4191; -.
DR   GeneCards; MDH2; -.
DR   HGNC; HGNC:6971; MDH2.
DR   HPA; HPA019714; -.
DR   HPA; HPA019716; -.
DR   HPA; HPA019848; -.
DR   HPA; HPA026720; -.
DR   MIM; 154100; gene.
DR   MIM; 617339; phenotype.
DR   neXtProt; NX_P40926; -.
DR   OpenTargets; ENSG00000146701; -.
DR   PharmGKB; PA30716; -.
DR   eggNOG; KOG1494; Eukaryota.
DR   eggNOG; COG0039; LUCA.
DR   GeneTree; ENSGT00390000016686; -.
DR   HOGENOM; HOG000213792; -.
DR   HOVERGEN; HBG001662; -.
DR   InParanoid; P40926; -.
DR   KO; K00026; -.
DR   OMA; VEVKGFA; -.
DR   OrthoDB; EOG091G0AVO; -.
DR   PhylomeDB; P40926; -.
DR   TreeFam; TF300834; -.
DR   BioCyc; MetaCyc:HS07366-MONOMER; -.
DR   Reactome; R-HSA-70263; Gluconeogenesis.
DR   Reactome; R-HSA-71403; Citric acid cycle (TCA cycle).
DR   ChiTaRS; MDH2; human.
DR   EvolutionaryTrace; P40926; -.
DR   GeneWiki; Malate_dehydrogenase_2; -.
DR   GenomeRNAi; 4191; -.
DR   PRO; PR:P40926; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000146701; -.
DR   CleanEx; HS_MDH2; -.
DR   ExpressionAtlas; P40926; baseline and differential.
DR   Genevisible; P40926; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IEA:Ensembl.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0030060; F:L-malate dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0046554; F:malate dehydrogenase (NADP+) activity; IEA:Ensembl.
DR   GO; GO:0043621; F:protein self-association; IEA:Ensembl.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0009060; P:aerobic respiration; IDA:UniProtKB.
DR   GO; GO:0006094; P:gluconeogenesis; TAS:Reactome.
DR   GO; GO:0006475; P:internal protein amino acid acetylation; IDA:UniProtKB.
DR   GO; GO:0006108; P:malate metabolic process; IDA:UniProtKB.
DR   GO; GO:0006734; P:NADH metabolic process; IEA:Ensembl.
DR   GO; GO:0006107; P:oxaloacetate metabolic process; IEA:Ensembl.
DR   GO; GO:0006099; P:tricarboxylic acid cycle; TAS:Reactome.
DR   InterPro; IPR001557; L-lactate/malate_DH.
DR   InterPro; IPR022383; Lactate/malate_DH_C.
DR   InterPro; IPR001236; Lactate/malate_DH_N.
DR   InterPro; IPR015955; Lactate_DH/Glyco_Ohase_4_C.
DR   InterPro; IPR001252; Malate_DH_AS.
DR   InterPro; IPR010097; Malate_DH_type1.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   Pfam; PF02866; Ldh_1_C; 1.
DR   Pfam; PF00056; Ldh_1_N; 1.
DR   PIRSF; PIRSF000102; Lac_mal_DH; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   SUPFAM; SSF56327; SSF56327; 1.
DR   TIGRFAMs; TIGR01772; MDH_euk_gproteo; 1.
DR   PROSITE; PS00068; MDH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Disease mutation; Epilepsy; Glycoprotein; Mitochondrion; NAD;
KW   Oxidoreductase; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transit peptide; Tricarboxylic acid cycle.
FT   TRANSIT       1     24       Mitochondrion.
FT                                {ECO:0000250|UniProtKB:P00346}.
FT   CHAIN        25    338       Malate dehydrogenase, mitochondrial.
FT                                /FTId=PRO_0000018628.
FT   NP_BIND      31     37       NAD. {ECO:0000269|Ref.16}.
FT   NP_BIND     140    142       NAD. {ECO:0000269|Ref.16}.
FT   ACT_SITE    200    200       Proton acceptor.
FT                                {ECO:0000250|UniProtKB:P00346}.
FT   BINDING      57     57       NAD. {ECO:0000269|Ref.16}.
FT   BINDING     104    104       Substrate. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10004, ECO:0000269|Ref.16}.
FT   BINDING     110    110       Substrate. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10004, ECO:0000269|Ref.16}.
FT   BINDING     117    117       NAD. {ECO:0000269|Ref.16}.
FT   BINDING     142    142       Substrate. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10004, ECO:0000269|Ref.16}.
FT   BINDING     176    176       Substrate. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10004, ECO:0000269|Ref.16}.
FT   BINDING     251    251       NAD. {ECO:0000269|Ref.16}.
FT   MOD_RES      78     78       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P08249}.
FT   MOD_RES      78     78       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P08249}.
FT   MOD_RES      91     91       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P08249}.
FT   MOD_RES      91     91       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P08249}.
FT   MOD_RES     165    165       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     185    185       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861,
FT                                ECO:0000269|PubMed:20167786}.
FT   MOD_RES     185    185       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P08249}.
FT   MOD_RES     203    203       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P08249}.
FT   MOD_RES     215    215       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P08249}.
FT   MOD_RES     215    215       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P08249}.
FT   MOD_RES     239    239       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P08249}.
FT   MOD_RES     239    239       N6-malonyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q32LG3}.
FT   MOD_RES     239    239       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q32LG3}.
FT   MOD_RES     246    246       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     269    269       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P08249}.
FT   MOD_RES     296    296       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P08249}.
FT   MOD_RES     296    296       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P08249}.
FT   MOD_RES     301    301       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861,
FT                                ECO:0000269|PubMed:20167786}.
FT   MOD_RES     301    301       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q32LG3}.
FT   MOD_RES     307    307       N6-acetyllysine; alternate.
FT                                {ECO:0000269|PubMed:20167786}.
FT   MOD_RES     307    307       N6-malonyllysine; alternate.
FT                                {ECO:0000269|PubMed:21908771}.
FT   MOD_RES     307    307       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P08249}.
FT   MOD_RES     314    314       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861,
FT                                ECO:0000269|PubMed:20167786}.
FT   MOD_RES     314    314       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P08249}.
FT   MOD_RES     324    324       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P08249}.
FT   MOD_RES     324    324       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P08249}.
FT   MOD_RES     326    326       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     328    328       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q32LG3}.
FT   MOD_RES     328    328       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q32LG3}.
FT   MOD_RES     329    329       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     329    329       N6-malonyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q32LG3}.
FT   MOD_RES     335    335       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     335    335       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P08249}.
FT   CARBOHYD     33     33       O-linked (GlcNAc) serine.
FT                                {ECO:0000250|UniProtKB:P04636}.
FT   VAR_SEQ     144    185       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055312.
FT   VARIANT       9      9       A -> V (in dbSNP:rs17849553).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.1}.
FT                                /FTId=VAR_047787.
FT   VARIANT      37     37       G -> R (in EIEE51; severe defects in
FT                                aerobic respiration, when assayed in a
FT                                heterologous system).
FT                                {ECO:0000269|PubMed:27989324}.
FT                                /FTId=VAR_078001.
FT   VARIANT     133    133       P -> L (in EIEE51; decreased protein
FT                                abundance; strong decrease in malate
FT                                dehydrogenase activity; severe defects in
FT                                aerobic respiration, when assayed in a
FT                                heterologous system).
FT                                {ECO:0000269|PubMed:27989324}.
FT                                /FTId=VAR_078002.
FT   VARIANT     207    207       P -> L (in EIEE51; decreased protein
FT                                abundance; strong decrease in malate
FT                                dehydrogenase activity; severe defects in
FT                                aerobic respiration, when assayed in a
FT                                heterologous system).
FT                                {ECO:0000269|PubMed:27989324}.
FT                                /FTId=VAR_078003.
FT   MUTAGEN     185    185       K->R: No activation of enzyme activity on
FT                                treatment with TSA or NAM; when
FT                                associated with R-301; R-307 and R-314.
FT                                {ECO:0000269|PubMed:20167786}.
FT   MUTAGEN     301    301       K->R: No activation of enzyme activity on
FT                                treatment with TSA or NAM; when
FT                                associated with R-185; R-307 and R-314.
FT                                {ECO:0000269|PubMed:20167786}.
FT   MUTAGEN     307    307       K->R: No activation of enzyme activity on
FT                                treatment with TSA or NAM; when
FT                                associated with R-185; R-301 and R-314.
FT                                {ECO:0000269|PubMed:20167786}.
FT   MUTAGEN     314    314       K->R: No activation of enzyme activity on
FT                                treatment with TSA or NAM; when
FT                                associated with R-185; R-301 and R-307.
FT                                {ECO:0000269|PubMed:20167786}.
FT   CONFLICT    301    301       K -> R (in Ref. 2; BAG56955).
FT                                {ECO:0000305}.
FT   STRAND       25     30       {ECO:0000244|PDB:2DFD}.
FT   TURN         31     33       {ECO:0000244|PDB:2DFD}.
FT   HELIX        37     45       {ECO:0000244|PDB:2DFD}.
FT   STRAND       50     60       {ECO:0000244|PDB:2DFD}.
FT   HELIX        61     69       {ECO:0000244|PDB:2DFD}.
FT   STRAND       71     74       {ECO:0000244|PDB:2DFD}.
FT   STRAND       76     82       {ECO:0000244|PDB:2DFD}.
FT   TURN         83     85       {ECO:0000244|PDB:2DFD}.
FT   HELIX        86     90       {ECO:0000244|PDB:2DFD}.
FT   STRAND       94     98       {ECO:0000244|PDB:2DFD}.
FT   HELIX       110    113       {ECO:0000244|PDB:2DFD}.
FT   HELIX       114    131       {ECO:0000244|PDB:2DFD}.
FT   STRAND      135    139       {ECO:0000244|PDB:2DFD}.
FT   HELIX       144    157       {ECO:0000244|PDB:2DFD}.
FT   STRAND      165    168       {ECO:0000244|PDB:2DFD}.
FT   HELIX       171    185       {ECO:0000244|PDB:2DFD}.
FT   HELIX       189    191       {ECO:0000244|PDB:2DFD}.
FT   STRAND      196    198       {ECO:0000244|PDB:2DFD}.
FT   HELIX       202    204       {ECO:0000244|PDB:2DFD}.
FT   STRAND      205    207       {ECO:0000244|PDB:2DFD}.
FT   HELIX       209    211       {ECO:0000244|PDB:2DFD}.
FT   HELIX       220    241       {ECO:0000244|PDB:2DFD}.
FT   HELIX       249    266       {ECO:0000244|PDB:2DFD}.
FT   STRAND      273    279       {ECO:0000244|PDB:2DFD}.
FT   STRAND      282    295       {ECO:0000244|PDB:2DFD}.
FT   STRAND      298    302       {ECO:0000244|PDB:2DFD}.
FT   HELIX       310    335       {ECO:0000244|PDB:2DFD}.
SQ   SEQUENCE   338 AA;  35503 MW;  AAB9F5E5B2FBC8CA CRC64;
     MLSALARPAS AALRRSFSTS AQNNAKVAVL GASGGIGQPL SLLLKNSPLV SRLTLYDIAH
     TPGVAADLSH IETKAAVKGY LGPEQLPDCL KGCDVVVIPA GVPRKPGMTR DDLFNTNATI
     VATLTAACAQ HCPEAMICVI ANPVNSTIPI TAEVFKKHGV YNPNKIFGVT TLDIVRANTF
     VAELKGLDPA RVNVPVIGGH AGKTIIPLIS QCTPKVDFPQ DQLTALTGRI QEAGTEVVKA
     KAGAGSATLS MAYAGARFVF SLVDAMNGKE GVVECSFVKS QETECTYFST PLLLGKKGIE
     KNLGIGKVSS FEEKMISDAI PELKASIKKG EDFVKTLK
//
